Elevance Health, Inc. (ELV)
| Market Cap | 66.30B |
| Revenue (ttm) | 189.25B |
| Net Income (ttm) | 5.36B |
| Shares Out | 225.18M |
| EPS (ttm) | 23.39 |
| PE Ratio | 12.59 |
| Forward PE | 9.46 |
| Dividend | $6.84 (2.32%) |
| Ex-Dividend Date | Sep 10, 2025 |
| Volume | 2,367,351 |
| Open | 294.09 |
| Previous Close | 292.48 |
| Day's Range | 291.57 - 298.91 |
| 52-Week Range | 273.71 - 567.26 |
| Beta | 0.59 |
| Analysts | Buy |
| Price Target | 416.86 (+41.58%) |
| Earnings Date | Jul 17, 2025 |
About ELV
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, a... [Read more]
Financial Performance
In 2024, Elevance Health's revenue was $176.81 billion, an increase of 3.19% compared to the previous year's $171.34 billion. Earnings were $5.98 billion, a decrease of -0.12%.
Financial StatementsAnalyst Forecast
According to 15 analysts, the average rating for ELV stock is "Buy." The 12-month stock price target is $416.86, which is an increase of 41.58% from the latest price.
News
3 SWANs On Sale
Our focus for today includes BMY, REXR, and ELV. The trio offers a safe 4.2% dividend yield, an A- credit rating average, and a 27% weighted discount to fair value. Bristol-Myers Squibb possesses a li...
Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts
Insmed, Intuitive Surgical, and IDEXX Laboratories were top contributors, driven by strong drug pipelines, innovation, and robust financial results. We exited UnitedHealth Group due to earnings misses...
Elevance Health Board Welcomes Steve Collis as New Director, Reflecting Ongoing Commitment to Governance Excellence
INDIANAPOLIS--(BUSINESS WIRE)--The board of directors of Elevance Health (NYSE: ELV) announced today that Steve Collis, a highly regarded global healthcare executive, will be joining the company's boa...
Elevance Health: CEO Buys As CareBridge Drives Strong Growth
On July 18, the CEO bought $2.4MM worth, after the sell-off following the last earnings call. Carelon Services is growing fast, supported by the December acquisition of CareBridge. The aging populatio...
Study Finds Digital Asthma Program Significantly Improves Symptom Control in Adults
INDIANAPOLIS--(BUSINESS WIRE)-- #DigitalHealth--Study by Elevance Health, UCI, in collaboration with Apple, highlights potential of digital health tools to reduce asthma burden in U.S. populations.
S&P 500 Gains and Losses Today: Pepsi Stock Turns Higher; Elevance Health Tumbles
Major U.S. equities indexes pushed higher Thursday as a report revealed an increase in retail sales in June, suggesting that consumer spending remains strong despite tariff concerns.
Top Stock Movers Now: PepsiCo, Elevance Health, CSX, and More
Major U.S. equities indexes were higher at midday Thursday in the wake of better-than-expected quarterly results from several major companies. The Dow, S&P 500, and Nasdaq all advanced.
Elevance Health, Inc. (ELV) Q2 2025 Earnings Call Transcript
Elevance Health, Inc. (NYSE:ELV) Q2 2025 Earnings Conference Call July 17, 2025 8:30 AM ET Company Participants Felicia Farr Norwood - Executive VP & President of Government Health Benefits Gail Kozi...
Elevance Stock Falls After Earnings. What It Means for UnitedHealth, Other Insurers.
The health insurer now expects 2025 earnings of just $30 a share, citing ongoing and industry-wide impact of elevated cost trends in ACA and Medicaid.
Most Managed Care Insurers Expected To See Q2 2025 Drops In Revenue, Net Income
A majority of publicly traded US health insurers are expected to post QoQ declines in revenue and net income in Q2, according to an S&P Global Market Intelligence analysis of sell-side analyst forecas...
Elevance cuts annual profit forecast on high medical costs
Elevance lowered its annual profit forecast on Thursday as it expects elevated medical costs in its government-backed plans to persist, sending its shares 7% lower in premarket trading.
Elevance Health Reports Second Quarter 2025 Results
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported second quarter 2025 results. "In the second quarter, Elevance Health made meaningful progress in delivering an experience that...
Elevance Health: Much Cheaper Than UNH, Yet No Drama
The market often misinterprets price declines as value. For Elevance Health, I see a disconnect between market cap and long-term earnings potential. Health sector valuations have dropped sharply, but ...
Elevance Health: Should You Buy ELV Stock Ahead Of Its Upcoming Earnings?
Elevance Health (NYSE:ELV) is set to report its earnings on Thursday, July 17, 2025. For traders focused on events, analyzing past stock performance surrounding earnings announcements can yield valuab...
Elevance Steps In As UnitedHealth Delays — Will It Set The Tone For Insurers?
Health insurer Elevance Health Inc. ELV is scheduled to release its second quarter 2025 financial results on July 17.
Eyes On Elevance Health, Not UnitedHealth, As First To Report Earnings
For years now, UnitedHealth Group has been the first of the major health insurers to report its quarterly earnings. And Wall Street analysts and investors have looked to the healthcare giant -- which ...
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Elevance To Contact Him Directly To Discuss Their Options
DEADLINE TOMORROW: Berger Montague Advises Elevance Health (NYSE: ELV) Investors to Contact the Firm Before July 11, 2025
PHILADELPHIA , July 10, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or the "Company") (NY...
ELV COURT NOTICE: Elevance Health, Inc. Investors may have been Affected by Fraud – Contact BFA Law by the July 11 Legal Deadline (NYSE:ELV)
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE: ELV) and certain of the ...
DEADLINE THIS WEEK: Berger Montague Advises Elevance Health (NYSE: ELV) Investors to Contact the Firm Before July 11, 2025
PHILADELPHIA , July 7, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or the "Company") (NYS...
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Elevance To Contact Him Directly To Discuss Their Options If you purchased or acquir...
Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2025 Results on July 17
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release second quarter 2025 financial results on July 17, 2025, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these...
ELV Shareholders Have the Right to Lead the Elevance Health, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELV
LOS ANGELES , July 2, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Elevance Health, Inc. ("Elevance" or "the Company") (NYSE: ELV) for violations of the f...
Top 15 High-Growth Dividend Stocks For July 2025
My Top 15 High-Growth Dividend Stocks outperformed SPY and VIG in June, gaining 6.15% versus SPY's 5.14% and VIG's 3.41%. The list's year-to-date return is 12.59%, beating SPY every month in 2025, tho...